Search research articles
Contact Us
Filters
Showing results (61-70 of 188) with videos related to
Page
of 19
Sort By:
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih
|
January 6, 2022
Severe Pulmonary Embolism, Thrombosis of Lower Extremity, Unexpected Mild Renal Disorder in MPO-ANCA Associated Vasculitis: A Case Report
Zhong-Hua Liao, Jun-Tao Feng, Jia-le Tang, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
July 5, 2017
Abnormality of Klotho Signaling Is Involved in Polycystic Ovary Syndrome
Zenghui Mao, Liqing Fan, Qiao Yu, et al.
Immunotherapy
|
January 30, 2023
Association of immune-related adverse events and efficacy in advanced non-small-cell lung cancer: a systematic review and meta-analysis
Yu Zhou, Haizhu Chen, Le Tang, et al.
Clinical Lung Cancer
|
January 7, 2026
Efficacy and Safety of Firmonertinib Plus Anlotinib as First-Line Treatment for Advanced NSCLC With EGFR Mutations: A Single-Arm, Phase I/II Trial
Huiyang Shi, Haohua Zhu, Le Tang, et al.
Disease Markers
|
November 1, 2022
DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis
Liling Huang, Tongji Xie, Fuqiang Zhao, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
June 14, 2021
Combined Treatment of Cinobufotalin and Gefitinib Exhibits Potent Efficacy against Lung Cancer
Youxi Han, Ronghui Ma, Guolei Cao, et al.
Biomarker Research
|
June 5, 2024
Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma
Liyuan Dai, Guangyu Fan, Tongji Xie, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2022
Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients
Yu Feng, Le Tang, Hongyu Wang, et al.
Journal of Cancer Research and Clinical Oncology
|
April 22, 2025
Clinical implications of miR-195 in cancer: mechanisms, potential applications, and therapeutic strategies
Shuli Xu, Lan He, Yan Chen, et al.
Thoracic Cancer
|
August 8, 2023
Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis
Yu Feng, Yunxia Tao, Haizhu Chen, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 188) with videos related to
Sort By:
Page
of 19
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih
|
January 6, 2022
Severe Pulmonary Embolism, Thrombosis of Lower Extremity, Unexpected Mild Renal Disorder in MPO-ANCA Associated Vasculitis: A Case Report
Zhong-Hua Liao, Jun-Tao Feng, Jia-le Tang, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
July 5, 2017
Abnormality of Klotho Signaling Is Involved in Polycystic Ovary Syndrome
Zenghui Mao, Liqing Fan, Qiao Yu, et al.
Immunotherapy
|
January 30, 2023
Association of immune-related adverse events and efficacy in advanced non-small-cell lung cancer: a systematic review and meta-analysis
Yu Zhou, Haizhu Chen, Le Tang, et al.
Clinical Lung Cancer
|
January 7, 2026
Efficacy and Safety of Firmonertinib Plus Anlotinib as First-Line Treatment for Advanced NSCLC With EGFR Mutations: A Single-Arm, Phase I/II Trial
Huiyang Shi, Haohua Zhu, Le Tang, et al.
Disease Markers
|
November 1, 2022
DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis
Liling Huang, Tongji Xie, Fuqiang Zhao, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
June 14, 2021
Combined Treatment of Cinobufotalin and Gefitinib Exhibits Potent Efficacy against Lung Cancer
Youxi Han, Ronghui Ma, Guolei Cao, et al.
Biomarker Research
|
June 5, 2024
Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma
Liyuan Dai, Guangyu Fan, Tongji Xie, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2022
Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients
Yu Feng, Le Tang, Hongyu Wang, et al.
Journal of Cancer Research and Clinical Oncology
|
April 22, 2025
Clinical implications of miR-195 in cancer: mechanisms, potential applications, and therapeutic strategies
Shuli Xu, Lan He, Yan Chen, et al.
Thoracic Cancer
|
August 8, 2023
Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis
Yu Feng, Yunxia Tao, Haizhu Chen, et al.
Page
of 19